| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000025017 |
| Receipt No. | R000028549 |
| Official scientific title of the study | Safety and Effectiveness of transcatheter arterial micro-embolization as a treatment for ulnar collateral ligament injuries in baseball players refractory to conservative treatment |
| Date of disclosure of the study information | 2016/11/29 |
| Last modified on | 2016/11/28 (Ver. 2) |
| Basic information | ||||
| Official scientific title of the study | Safety and Effectiveness of transcatheter arterial micro-embolization as a treatment for ulnar collateral ligament injuries in baseball players refractory to conservative treatment | |||
| Title of the study (Brief title) | TAME for baseball player with resistant UCL Injuries | |||
| Region |
|
|||
| Condition | ||
| Condition | Ulnar collateral ligament injuries in baseball player refractory to conservative treatment | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To study the safety and effectiveness of transcatheter arterial micro-embolization for baseball player with ulnar collateral ligament injuries refractory to conservative treatment |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Phase I,II |
| Assessment | |
| Primary outcomes | Prevalence of adverse events |
| Key secondary outcomes | Rates of return to play
Rates of return to the same level of play or higher The change of Pain NRS scores The Change of Kerlan-Jobe Orthopaedic Clinic Shoulder and Elbow Score The Change of Disabilities of the Arm, Shoulder and Hand Score The change of Pitching Velocity The change of Number of Full strength throwing per day The change of MRI findings The change of US findings |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Transcatheter arterial micro-embolization | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Baseball player
2.Diagnosed as UCL injuries by physical examination and confirmed by MRI 3.The patients who can not perform pitching due to his/her pain. 4.The patients who failed to improved his/her symptoms by nonoperative management for more than 3 months |
|||
| Key exclusion criteria | The patients whose chief complain is not pain
The patients who are not available for 1 year follow up the patients who have history of Allergy to contrast enhanced |
|||
| Target sample size | 33 | |||
| Research contact person | |
| Name of lead principal investigator | Yuji Okuno |
| Organization | Edogawa Hospital |
| Division name | Musculoskeletal Intervention Center |
| Address | Higashikoiwa 2-24-18, Edogawa-ku, Tokyo, Japan |
| TEL | 03-3673-1221 |
| okuno@edogawa.or.jp | |
| Public contact | |
| Name of contact person | Yuji Okuno |
| Organization | Edogawa Hospital |
| Division name | Musculoskeletal Intervention Center |
| Address | Higashikoiwa 2-24-18, Edogawa-ku, Tokyo, Japan |
| TEL | 03-3673-1221 |
| Homepage URL | |
| okuno@edogawa.or.jp | |
| Sponsor | |
| Institute | Edogawa Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Orthopedic department of Edogawa Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028549 |